Serum mir-181a as a potential serological biomarker for metabolic dysfunction-associated fatty liver disease: A cross sectional study.

Saved in:
Bibliographic Details
Title: Serum mir-181a as a potential serological biomarker for metabolic dysfunction-associated fatty liver disease: A cross sectional study.
Authors: Xiong KG; Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China., Kong JF, Lin TS, Lin QB, Ke KY
Source: Medicine [Medicine (Baltimore)] 2026 Jan 23; Vol. 105 (4), pp. e47290.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-5964
DOI:10.1097/MD.0000000000047290